Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $27.72 Analyst target: $22.50 Upside: -18.83%
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
See the full interactive analysis & chart →Informational only — not investment advice.